Danaher Corporation (DHR): Price and Financial Metrics


Danaher Corporation (DHR)

Today's Latest Price: $202.05 USD

3.35 (-1.63%)

Updated Aug 10 4:10pm

Add DHR to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 59 in Industrial - Machinery

See all "A" rated Strong Buy stocks

DHR Stock Summary

  • With a market capitalization of $145,712,575,120, Danaher Corp has a greater market value than 98.85% of US stocks.
  • Danaher Corp's stock had its IPO on November 5, 1987, making it an older stock than 90.62% of US equities in our set.
  • With a year-over-year growth in debt of 117.39%, Danaher Corp's debt growth rate surpasses 88.96% of about US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Danaher Corp are SYK, FTV, BAX, TMO, and ABB.
  • DHR's SEC filings can be seen here. And to visit Danaher Corp's official web site, go to www.danaher.com.
DHR Daily Price Range
DHR 52-Week Price Range

DHR Stock Price Chart Technical Analysis Charts


DHR Price/Volume Stats

Current price $202.05 52-week high $207.66
Prev. close $205.40 52-week low $119.60
Day low $201.36 Volume 2,141,279
Day high $205.84 Avg. volume 3,169,726
50-day MA $184.10 Dividend yield 0.35%
200-day MA $159.11 Market Cap 143.34B

Danaher Corporation (DHR) Company Bio


Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company was founded in 1969 and is based in Washington, the District of Columbia.

DHR Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$202.05$58.04 -72%

Below please find a table outlining a discounted cash flow forecast for DHR, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Danaher Corp ranked in the 21th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. In terms of the factors that were most noteworthy in this DCF analysis for DHR, they are:

  • DHR's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 31.12% of tickers in our DCF set.
  • The weighted average cost of capital for the company is 8. This value is greater than merely 24.64% stocks in the Healthcare sector that generate free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-72%
1%-72%
2%-72%
3%-71%
4%-71%
5%-71%

Want more companies with a valuation profile/forecast similar to that of Danaher Corp? See CPIX, AZN, RMD, BHC, and BIO.





DHR Latest News Stream


Event/Time News Detail
Loading, please wait...

DHR Latest Social Stream


Loading social stream, please wait...

View Full DHR Social Stream

Latest DHR News From Around the Web

Below are the latest news stories about Danaher Corp that investors may wish to consider to help them evaluate DHR as an investment opportunity.

Should You Buy Danaher Stock at Its All-Time High?

The healthcare-focused company continues to power higher. Here's what's driving it, and why the stock can continue to appreciate.

Yahoo | July 30, 2020

Earnings Estimates Rising for Danaher (DHR): Will It Gain?

Danaher (DHR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Yahoo | July 29, 2020

Danaher Corporation EPS beats by $0.35, beats on revenue

Danaher Corporation (DHR): Q2 Non-GAAP EPS of $1.44 beats by $0.35; GAAP EPS of $1.24 beats by $0.50.Revenue of $5.3B (+19.4% Y/Y) beats by $290M.Core revenue growth of -0.5% vs. consensus of -5.0%.Press Release...

Seeking Alpha | July 23, 2020

Danaher Corporation 2020 Q2 - Results - Earnings Call Presentation

The following slide deck was published by Danaher Corporation in conjunction with their 2020 Q2 earnings call....

SA Transcripts on Seeking Alpha | July 23, 2020

Danaher Q2 top-line up 19%; beats Q2 consensus (NYSE:DHR)

Danaher Corporation (DHR) Q2 results: Revenues: $5,297.4M (+19.2%). Net Income: $892.7M (+26.0%); EPS: $1.24 (+37.8%); non-GAAP EPS: $1.44 (+32.1%). CF Ops

Seeking Alpha | July 23, 2020

Read More 'DHR' Stories Here

DHR Price Returns

1-mo 10.01%
3-mo 26.20%
6-mo 23.63%
1-year 44.69%
3-year 157.41%
5-year 130.50%
YTD 31.97%
2019 49.55%
2018 11.80%
2017 20.01%
2016 -15.65%
2015 9.04%

DHR Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full DHR Dividend History

Continue Researching DHR

Want to see what other sources are saying about Danaher Corp's financials and stock price? Try the links below:

Danaher Corp (DHR) Stock Price | Nasdaq
Danaher Corp (DHR) Stock Quote, History and News - Yahoo Finance
Danaher Corp (DHR) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.956 seconds.